Grzegorz Basak

9.8k total citations · 3 hit papers
164 papers, 3.7k citations indexed

About

Grzegorz Basak is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Grzegorz Basak has authored 164 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Hematology, 55 papers in Oncology and 27 papers in Molecular Biology. Recurrent topics in Grzegorz Basak's work include Hematopoietic Stem Cell Transplantation (60 papers), Acute Myeloid Leukemia Research (24 papers) and CAR-T cell therapy research (20 papers). Grzegorz Basak is often cited by papers focused on Hematopoietic Stem Cell Transplantation (60 papers), Acute Myeloid Leukemia Research (24 papers) and CAR-T cell therapy research (20 papers). Grzegorz Basak collaborates with scholars based in Poland, Germany and France. Grzegorz Basak's co-authors include Rafael F. Duarte, Mohamad Mohty, Nicolaus Kröger, W Wiktor-Jędrzejczak, John A. Snowden, Ibrahim Yakoub‐Agha, Arjan C. Lankester, Jarosław Biliński, Christian Chabannon and Marcin Jasiński and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Grzegorz Basak

145 papers receiving 3.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment

2018 266 citations Hélène Schoemans, Tapani Ruutu et al. Bone Marrow Transplantation profile →
Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

2021 223 citations Jakob Passweg, Helen Baldomero et al. Bone Marrow Transplantation profile →
Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

2022 159 citations John A. Snowden, Selim Corbacioglu et al. Bone Marrow Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Grzegorz Basak Poland	30	1.7k	1.2k	880	735	461	164	3.7k
Florent Malard France	32	2.1k 1.2×	1.1k 0.9×	1.0k 1.2×	946 1.3×	643 1.4×	145	3.6k
Yi‐Bin Chen United States	35	2.1k 1.2×	1.5k 1.2×	1.1k 1.3×	1.1k 1.5×	561 1.2×	197	4.9k
Ronald Sobecks United States	29	2.2k 1.2×	1.2k 1.0×	669 0.8×	592 0.8×	679 1.5×	255	3.5k
Mohamed A. Kharfan‐Dabaja United States	34	2.2k 1.3×	1.7k 1.5×	760 0.9×	947 1.3×	681 1.5×	313	4.5k
Koji Kato Japan	34	2.2k 1.3×	1.5k 1.2×	584 0.7×	713 1.0×	957 2.1×	208	4.7k
Michael Potter United Kingdom	32	1.8k 1.0×	767 0.6×	710 0.8×	675 0.9×	760 1.6×	116	3.3k
Hartmut Link Germany	36	2.4k 1.4×	1.9k 1.6×	846 1.0×	501 0.7×	344 0.7×	142	5.1k
Biju George India	37	2.8k 1.6×	751 0.6×	1.6k 1.8×	472 0.6×	964 2.1×	299	5.0k
Andrzej Hellmann Poland	24	2.0k 1.2×	1.1k 1.0×	1.1k 1.3×	940 1.3×	290 0.6×	130	4.0k
Jörg Halter Switzerland	33	1.6k 0.9×	685 0.6×	281 0.3×	624 0.8×	545 1.2×	161	3.5k

Countries citing papers authored by Grzegorz Basak

Since Specialization

Citations

This map shows the geographic impact of Grzegorz Basak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grzegorz Basak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grzegorz Basak more than expected).

Fields of papers citing papers by Grzegorz Basak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grzegorz Basak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grzegorz Basak. The network helps show where Grzegorz Basak may publish in the future.

Co-authorship network of co-authors of Grzegorz Basak

This figure shows the co-authorship network connecting the top 25 collaborators of Grzegorz Basak. A scholar is included among the top collaborators of Grzegorz Basak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grzegorz Basak. Grzegorz Basak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Olejarz, Wioletta, et al.. (2025). Nephrotoxicity in CAR-T Cell Therapy. Transplantation and Cellular Therapy. 31(7). 407–418. 3 indexed citations

Łacina, Piotr, Anna Czyż, Maria Bieniaszewska, et al.. (2024). Soluble MICA concentrations and genetic variability of MICA and its NKG2D receptor as factors affecting Graft-versus-Host Disease development after allogeneic haematopoietic stem cell transplantation. Human Immunology. 85(6). 111147–111147.

Tomaszewska, Agnieszka, et al.. (2024). One Novel Urinary Biomarkers of Acute Kidney Injury in Patients After Allogeneic Hematopoetic Stem Cell Transplantation. Transplantation Proceedings. 56(4). 904–906. 1 indexed citations

Dudziński, Marek, et al.. (2023). Supporting the Diagnosis of Fabry Disease Using a Natural Language Processing-Based Approach. Journal of Clinical Medicine. 12(10). 3599–3599. 12 indexed citations

Ruutu, Tapani, Christophe Peczynski, Nicolaus Kröger, et al.. (2023). The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working Party. Bone Marrow Transplantation. 59(2). 255–263. 3 indexed citations

Perić, Zinaida, Grzegorz Basak, Christian Koenecke, et al.. (2023). Understanding the Needs and Lived Experiences of Patients With Graft-Versus-Host Disease: Real-World European Public Social Media Listening Study. JMIR Cancer. 9. e42905–e42905. 3 indexed citations

Drozd‐Sokołowska, Joanna, Anna Waszczuk‐Gajda, Magdalena Witkowska, et al.. (2022). Bing-Neel Syndrome, a Rare Presentation of Waldenström Macroglobulinemia—A Multicenter Report by the Polish Lymphoma Research Group. Journal of Clinical Medicine. 11(15). 4447–4447. 1 indexed citations

Hoser, Grażyna, Andrew Want, Wioleta Grabowska, et al.. (2022). Novel Dicarboximide BK124.1 Breaks Multidrug Resistance and Shows Anticancer Efficacy in Chronic Myeloid Leukemia Preclinical Models and Patients’ CD34+/CD38− Leukemia Stem Cells. Cancers. 14(15). 3641–3641. 3 indexed citations

Swatler, Julian, Marta Brewińska‐Olchowik, Sara De Biasi, et al.. (2022). 4-1BBL–containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells. Blood Advances. 6(6). 1879–1894. 26 indexed citations

10.

Dwilewicz‐Trojaczek, Jadwiga, Joanna Drozd‐Sokołowska, Piotr Boguradzki, et al.. (2021). Prevalence of hypogammaglobulinemia and its management with subcutaneous immunoglobulin supplementation in patients after allogeneic hematopoietic stem cell transplantation—a single-center analysis. Annals of Hematology. 100(12). 3007–3016. 3 indexed citations

11.

Grzywa, Tomasz M., Anna Sosnowska, Zuzanna Rydzyńska, et al.. (2021). Potent but transient immunosuppression of T-cells is a general feature of CD71+ erythroid cells. Communications Biology. 4(1). 1384–1384. 22 indexed citations

12.

Zini, Gina, Giuseppe d’Onofrio, Wendy N. Erber, et al.. (2021). 2021 update of the 2012 ICSH Recommendations for identification, diagnostic value, and quantitation of schistocytes: Impact and revisions. International Journal of Laboratory Hematology. 43(6). 1264–1271. 19 indexed citations

13.

Passweg, Jakob, Helen Baldomero, Christian Chabannon, et al.. (2021). Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years. Bone Marrow Transplantation. 56(7). 1651–1664. 223 indexed citations breakdown →

14.

Ljungman, Per, Małgorzata Mikulska, Rafael de la Cámara, et al.. (2020). Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy. Bone Marrow Transplantation. 56(3). 755–755. 11 indexed citations

15.

Penack, Olaf, Christophe Peczynski, Mohamad Mohty, et al.. (2020). How much has allogeneic stem cell transplant–related mortality improved since the 1980s? A retrospective analysis from the EBMT. Blood Advances. 4(24). 6283–6290. 102 indexed citations

16.

Hayashi, Hiromi, Annalisa Ruggeri, Fernanda Volt, et al.. (2018). Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria. Bone Marrow Transplantation. 53(4). 417–421. 1 indexed citations

17.

Głodkowska‐Mrówka, Eliza, Piotr Mrówka, Grzegorz Basak, et al.. (2014). Statins inhibit ABCB1 and ABCG2 drug transporter activity in chronic myeloid leukemia cells and potentiate antileukemic effects of imatinib. Experimental Hematology. 42(6). 439–447. 18 indexed citations

18.

Basak, Grzegorz, Elżbieta Urbanowska, Magdalena Witkowska, et al.. (2010). CXCR4 inhibitor plerixafor and G-CSF allow for an effective peripheral blood stem cell collection in patients who failed previous mobilization attempt. 1(1). 1 indexed citations

19.

Basak, Grzegorz, Wanda Knopińska‐Posłuszny, Magdalena Matuszak, et al.. (2010). Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)—Polish compassionate use experience. Annals of Hematology. 90(5). 557–568. 29 indexed citations

20.

Stokłosa, Tomasz, Tomasz Popławski, Mateusz Koptyra, et al.. (2008). BCR/ABL Inhibits Mismatch Repair to Protect from Apoptosis and Induce Point Mutations. Cancer Research. 68(8). 2576–2580. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact